Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Pre-Surgical Intervention Study for Evaluating the Effect of Metformin on Breast Cancer Proliferation

NCT00930579 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT00930579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00930579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Pre-Surgical Intervention Study for Evaluating the Effect of Metformin on Breast Cancer Proliferation
Lead sponsor
Columbia University
Phase
Phase 2
Overall status
Completed
Start date
October 16, 2009
Completion date
January 9, 2017
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer